首页 > 最新文献

Nucleosides, Nucleotides & Nucleic Acids最新文献

英文 中文
Current updates on genetic spectrum of usher syndrome. 目前有关 usher 综合征遗传谱的最新进展。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-05-08 DOI: 10.1080/15257770.2024.2344194
Farman Ullah, Muhammad Zeeshan Ali, Safeer Ahmad, Muhammad Muzammal, Saadullah Khan, Jabbar Khan, Muzammil Ahmad Khan

Usher syndrome (USH) is a genetic disorder that is characterized by sensorineural hearing loss (HL) and visual abnormality, i.e., loss of night vision and side (peripheral) vision. Usher syndrome is categorized into four subtypes (USH1, USH2, USH3, USH4) on the basis of phenotypic spectrum. Profound hearing loss (HL), vestibular are flexia and language disturbance are typically associated with Usher type 1, while USH2 is linked with moderate to severe level of congenital HL. USH3 has late onset of deafness in life (referred to as "postlingual"), inconstant vestibular abnormality and onset of retinitis pigmentosa (RP) typically in 2nd decade of life. Patients with USH4 have no vestibular impairment and have late onset of retinitis pigmentosa (RP) and sensorineural hearing loss. Until now, 15 genetic loci have been reported to be linked with all types of USH. Among reported USH loci, nine are related to be involved in USH1, three in USH2, two in USH3 and one locus in USH4, respectively. Current review has described different types of Usher syndrome and their molecular genetics, and role of usher proteins in sensory organs. Moreover, we also suggested certain candidate genes for uncharacterized loci that may help the molecular geneticist to reach their target easily. Conclusion: The current catalogue of USH genetic data may assist in genetic counseling, genetic diagnosis, and genotype-phenotype correlation.

乌谢尔综合征(USH)是一种遗传性疾病,其特征是感音神经性听力损失(HL)和视觉异常,即夜视和侧(周边)视力丧失。根据表型谱,乌谢尔综合征可分为四个亚型(USH1、USH2、USH3 和 USH4)。乌谢尔 1 型通常伴有严重的听力损失(HL)、前庭功能障碍和语言障碍,而乌谢尔 2 型则伴有中度到重度的先天性听力损失。USH3 晚期才出现耳聋(称为 "舌后"),前庭异常不稳定,视网膜色素变性(RP)通常在出生后的第二个十年发病。USH4 患者没有前庭功能障碍,但色素性视网膜炎(RP)和感音神经性听力损失发病较晚。迄今为止,已有 15 个基因位点与所有类型的 USH 相关。在已报道的 USH 基因位点中,9 个与 USH1 有关,3 个与 USH2 有关,2 个与 USH3 有关,1 个与 USH4 有关。本综述描述了不同类型的乌谢尔综合征及其分子遗传学,以及乌谢尔蛋白在感觉器官中的作用。此外,我们还提出了一些未表征基因座的候选基因,这些候选基因可能有助于分子遗传学家轻松找到目标基因。结论目前的乌舍氏症遗传学数据目录可能有助于遗传咨询、遗传诊断以及基因型与表型的相关性。
{"title":"Current updates on genetic spectrum of usher syndrome.","authors":"Farman Ullah, Muhammad Zeeshan Ali, Safeer Ahmad, Muhammad Muzammal, Saadullah Khan, Jabbar Khan, Muzammil Ahmad Khan","doi":"10.1080/15257770.2024.2344194","DOIUrl":"https://doi.org/10.1080/15257770.2024.2344194","url":null,"abstract":"<p><p>Usher syndrome (USH) is a genetic disorder that is characterized by sensorineural hearing loss (HL) and visual abnormality, i.e., loss of night vision and side (peripheral) vision. Usher syndrome is categorized into four subtypes (USH1, USH2, USH3, USH4) on the basis of phenotypic spectrum. Profound hearing loss (HL), vestibular are flexia and language disturbance are typically associated with Usher type 1, while USH2 is linked with moderate to severe level of congenital HL. USH3 has late onset of deafness in life (referred to as \"postlingual\"), inconstant vestibular abnormality and onset of retinitis pigmentosa (RP) typically in 2nd decade of life. Patients with USH4 have no vestibular impairment and have late onset of retinitis pigmentosa (RP) and sensorineural hearing loss. Until now, 15 genetic loci have been reported to be linked with all types of USH. Among reported USH loci, nine are related to be involved in USH1, three in USH2, two in USH3 and one locus in USH4, respectively. Current review has described different types of Usher syndrome and their molecular genetics, and role of usher proteins in sensory organs. Moreover, we also suggested certain candidate genes for uncharacterized loci that may help the molecular geneticist to reach their target easily. Conclusion: The current catalogue of USH genetic data may assist in genetic counseling, genetic diagnosis, and genotype-phenotype correlation.</p>","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value and immunological role of MMRN1: a rising star in cancer. MMRN1 的预后价值和免疫学作用:癌症中的一颗新星。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-05-07 DOI: 10.1080/15257770.2024.2335680
Qing Zhou, Ying Liu, Jieyu Zhou, Wenling Zhang

Background: Multimerin 1 (MMRN1) is a factor V binding protein, which can support platelet adhesion and thrombus formation. In recent years, the role of MMRN1 in cancer has begun to attract attention. But systematic studies in this area are lacking. Therefore, we used bioinformatics methods to analyze MMRN1 in tumors to reveal the possible role of MMRN1.

Methods: Using the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) database, we obtained relevant data for analyzing MMRN1. Using Gene Expression Profiling Interactive Analysis (GEPIA), Human Protein Atlas (HPA), TCGA, GeneMANIA, and cBioPortal, we explored the potential role of MMRN1 in different types of tumors. Tumor Immune System Interactions and Drug Bank (TISIDB) and Sangerbox were used to analyze the correlation between MMRN1 and tumor immunity. Gene set cancer analysis (GSCA) and UALCAN were used to analyze the methylation of MMRN1. GSCA was also used to analyze the drug sensitivity of MMRN1.

Results: MMRN1 is down-regulated in most cancer types and is closely related to the prognosis of cancer patients. Interestingly, in most tumors, MMRN1 is positively correlated with immune -related genes. In addition, we observed different levels of methylation and mutations in different types of tumors. Drug sensitivity analysis found that MMRN1 was negatively correlated with several drugs, including GW-2580 and TL-1-85, suggesting that it can be used to develop potential anticancer therapies.

Conclusion: Our analysis demonstrated a significant relationship between MMRN1 and prognosis, tumor immunity, and drug sensitivity of several tumors. As a rising star in cancer, it needs further research.

背景:多聚蛋白1(MMRN1)是一种因子V结合蛋白,可支持血小板粘附和血栓形成。近年来,MMRN1在癌症中的作用开始受到关注。但目前还缺乏这方面的系统研究。因此,我们利用生物信息学方法对肿瘤中的 MMRN1 进行了分析,以揭示 MMRN1 的可能作用:利用癌症基因组图谱(TCGA)和基因型-组织表达(GTEx)数据库,我们获得了分析 MMRN1 的相关数据。利用基因表达谱交互分析(GEPIA)、人类蛋白质图谱(HPA)、TCGA、GeneMANIA和cBioPortal,我们探索了MMRN1在不同类型肿瘤中的潜在作用。肿瘤免疫系统相互作用与药物库(TISIDB)和Sangerbox用于分析MMRN1与肿瘤免疫之间的相关性。基因组癌症分析(GSCA)和 UALCAN 用于分析 MMRN1 的甲基化情况。GSCA还用于分析MMRN1的药物敏感性:结果:MMRN1在大多数癌症类型中下调,并与癌症患者的预后密切相关。有趣的是,在大多数肿瘤中,MMRN1与免疫相关基因呈正相关。此外,我们还在不同类型的肿瘤中观察到不同程度的甲基化和突变。药物敏感性分析发现,MMRN1与包括GW-2580和TL-1-85在内的几种药物呈负相关,这表明它可用于开发潜在的抗癌疗法:我们的分析表明,MMRN1与多种肿瘤的预后、肿瘤免疫力和药物敏感性之间存在重要关系。作为癌症领域的后起之秀,它还需要进一步研究。
{"title":"Prognostic value and immunological role of MMRN1: a rising star in cancer.","authors":"Qing Zhou, Ying Liu, Jieyu Zhou, Wenling Zhang","doi":"10.1080/15257770.2024.2335680","DOIUrl":"https://doi.org/10.1080/15257770.2024.2335680","url":null,"abstract":"<p><strong>Background: </strong>Multimerin 1 (MMRN1) is a factor V binding protein, which can support platelet adhesion and thrombus formation. In recent years, the role of MMRN1 in cancer has begun to attract attention. But systematic studies in this area are lacking. Therefore, we used bioinformatics methods to analyze MMRN1 in tumors to reveal the possible role of MMRN1.</p><p><strong>Methods: </strong>Using the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression (GTEx) database, we obtained relevant data for analyzing MMRN1. Using Gene Expression Profiling Interactive Analysis (GEPIA), Human Protein Atlas (HPA), TCGA, GeneMANIA, and cBioPortal, we explored the potential role of MMRN1 in different types of tumors. Tumor Immune System Interactions and Drug Bank (TISIDB) and Sangerbox were used to analyze the correlation between MMRN1 and tumor immunity. Gene set cancer analysis (GSCA) and UALCAN were used to analyze the methylation of MMRN1. GSCA was also used to analyze the drug sensitivity of MMRN1.</p><p><strong>Results: </strong>MMRN1 is down-regulated in most cancer types and is closely related to the prognosis of cancer patients. Interestingly, in most tumors, MMRN1 is positively correlated with immune -related genes. In addition, we observed different levels of methylation and mutations in different types of tumors. Drug sensitivity analysis found that MMRN1 was negatively correlated with several drugs, including GW-2580 and TL-1-85, suggesting that it can be used to develop potential anticancer therapies.</p><p><strong>Conclusion: </strong>Our analysis demonstrated a significant relationship between MMRN1 and prognosis, tumor immunity, and drug sensitivity of several tumors. As a rising star in cancer, it needs further research.</p>","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140876953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis, conformational analysis and antimicrobial activity of 10-benzyl-1,2,4-triazolo[4,3-b]1,2,4-triazino[5,6-b]indole acyclo C-nucleoside analogs. 10-苄基-1,2,4-三唑并[4,3-b]1,2,4-三嗪并[5,6-b]吲哚酰环 C 核苷类似物的合成、构象分析和抗菌活性。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-05-02 DOI: 10.1080/15257770.2024.2348741
Adel Z Nasr, Reda M Keshk, El-Sayed M Abdelrehim, Asmaa S Sallam

Condensation of 5-benzyl-3-hydrazino-1,2,4-triazino[5,6-b]indole with various sugar aldoses or ketoses gave the corresponding sugar hydrazones as single geometrical isomer or exist in E/Z tautomeric isomers. The hydrazones underwent heterocyclization with Fe(Ш)Cl3 to give the N2-adduct acyclo C-nucleosides: 3-(alditol-1yl)-10-benzyl-1,2,4-triazolo[4,3-b]1,2,4-triazino[5,6-b]indoles rather than the N4-adduct: 10-(alditol-1-yl)-3-benzyl-1,2,4-triazolo[3,4-c]1,2,4-triazino[5,6-b] indoles on the basis of chemical and UV spectral proofs. Conformational analysis of their polyacetates were studied. The new acyclo C-nucleosides were evaluated for antimicrobial activity.

将 5-苄基-3-肼基-1,2,4-三嗪并[5,6-b]吲哚与各种糖醛或糖酮缩合,可得到相应的糖肼,它们是单一的几何异构体,或存在 E/Z 同分异构体。这些酰肼与 Fe(Ш)Cl3 发生杂环化反应,得到 N2-加成酰环 C 核苷:3-(醛糖醇-1-基)-10-苄基-1,2,4-三唑并[4,3-b]1,2,4-三嗪并[5,6-b]吲哚,而不是 N4-加合物:在化学和紫外光谱证明的基础上,我们发现了 10-(醛糖醇-1-基)-3-苄基-1,2,4-三唑并[3,4-c]1,2,4-三嗪并[5,6-b]吲哚。对其聚乙酸酯的构象分析进行了研究。对新的酰环 C 核苷进行了抗菌活性评估。
{"title":"Synthesis, conformational analysis and antimicrobial activity of 10-benzyl-1,2,4-triazolo[4,3-<i>b</i>]1,2,4-triazino[5,6-<i>b</i>]indole acyclo <i>C</i>-nucleoside analogs.","authors":"Adel Z Nasr, Reda M Keshk, El-Sayed M Abdelrehim, Asmaa S Sallam","doi":"10.1080/15257770.2024.2348741","DOIUrl":"https://doi.org/10.1080/15257770.2024.2348741","url":null,"abstract":"<p><p>Condensation of 5-benzyl-3-hydrazino-1,2,4-triazino[5,6-<i>b</i>]indole with various sugar aldoses or ketoses gave the corresponding sugar hydrazones as single geometrical isomer or exist in <i>E/Z</i> tautomeric isomers. The hydrazones underwent heterocyclization with Fe(Ш)Cl<sub>3</sub> to give the <i>N2</i>-adduct acyclo <i>C</i>-nucleosides: 3-(alditol-1yl)-10-benzyl-1,2,4-triazolo[4,3-<i>b</i>]1,2,4-triazino[5,6-<i>b</i>]indoles rather than the <i>N4</i>-adduct: 10-(alditol-1-yl)-3-benzyl-1,2,4-triazolo[3,4-<i>c</i>]1,2,4-triazino[5,6-<i>b</i>] indoles on the basis of chemical and UV spectral proofs. Conformational analysis of their polyacetates were studied. The new acyclo <i>C</i>-nucleosides were evaluated for antimicrobial activity.</p>","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nucleic acids based integrated macromolecular complexes for SiRNA delivery: Recent advancements. 用于 SiRNA 递送的基于核酸的集成大分子复合物:最新进展。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-05-01 DOI: 10.1080/15257770.2024.2347499
Dilpreet Singh, Lovedeep Singh, Simranjeet Kaur, Akshita Arora

The therapeutic potential of small interfering RNA (siRNA) is monumental, offering a pathway to silence disease-causing genes with precision. However, the delivery of siRNA to target cells in-vivo remains a formidable challenge, owing to degradation by nucleases, poor cellular uptake and immunogenicity. This overview examines recent advancements in the design and application of nucleic acid-based integrated macromolecular complexes for the efficient delivery of siRNA. We dissect the innovative delivery vectors developed in recent years, including lipid-based nanoparticles, polymeric carriers, dendrimer complexes and hybrid systems that incorporate stimuli-responsive elements for targeted and controlled release. Advancements in bioconjugation techniques, active targeting strategies and nanotechnology-enabled delivery platforms are evaluated for their contribution to enhancing siRNA delivery. It also addresses the complex interplay between delivery system design and biological barriers, highlighting the dynamic progress and remaining hurdles in translating siRNA therapies from bench to bedside. By offering a comprehensive overview of current strategies and emerging technologies, we underscore the future directions and potential impact of siRNA delivery systems in personalized medicine.

小干扰 RNA(siRNA)具有巨大的治疗潜力,它提供了一种精确抑制致病基因的途径。然而,由于核酸酶降解、细胞吸收率低和免疫原性等原因,如何在体内将 siRNA 运送到靶细胞仍是一项艰巨的挑战。本综述探讨了高效递送 siRNA 的核酸基整合大分子复合物的设计和应用方面的最新进展。我们剖析了近年来开发的创新型递送载体,包括基于脂质的纳米颗粒、聚合物载体、树枝状聚合物复合物以及包含刺激响应元件的混合系统,以实现定向和可控释放。本研究评估了生物共轭技术、主动靶向策略和纳米技术驱动的递送平台等方面的进展,以了解它们对增强 siRNA 递送的贡献。报告还探讨了递送系统设计与生物障碍之间复杂的相互作用,强调了 siRNA 疗法从实验室到临床转化过程中的动态进展和仍然存在的障碍。通过对当前策略和新兴技术的全面概述,我们强调了 siRNA 递送系统在个性化医疗中的未来方向和潜在影响。
{"title":"Nucleic acids based integrated macromolecular complexes for SiRNA delivery: Recent advancements.","authors":"Dilpreet Singh, Lovedeep Singh, Simranjeet Kaur, Akshita Arora","doi":"10.1080/15257770.2024.2347499","DOIUrl":"https://doi.org/10.1080/15257770.2024.2347499","url":null,"abstract":"<p><p>The therapeutic potential of small interfering RNA (siRNA) is monumental, offering a pathway to silence disease-causing genes with precision. However, the delivery of siRNA to target cells <i>in-vivo</i> remains a formidable challenge, owing to degradation by nucleases, poor cellular uptake and immunogenicity. This overview examines recent advancements in the design and application of nucleic acid-based integrated macromolecular complexes for the efficient delivery of siRNA. We dissect the innovative delivery vectors developed in recent years, including lipid-based nanoparticles, polymeric carriers, dendrimer complexes and hybrid systems that incorporate stimuli-responsive elements for targeted and controlled release. Advancements in bioconjugation techniques, active targeting strategies and nanotechnology-enabled delivery platforms are evaluated for their contribution to enhancing siRNA delivery. It also addresses the complex interplay between delivery system design and biological barriers, highlighting the dynamic progress and remaining hurdles in translating siRNA therapies from bench to bedside. By offering a comprehensive overview of current strategies and emerging technologies, we underscore the future directions and potential impact of siRNA delivery systems in personalized medicine.</p>","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between polymorphism at codon 469 of the ICAM-1 gene and Henoch-Schönlein purpura in an Iranian cohort. 伊朗队列中 ICAM-1 基因第 469 个密码子的多态性与白癜风之间的关系。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-27 DOI: 10.1080/15257770.2024.2334360
Shima Salehi, Amir Hozhabrpour, Somayeh Takrim Nojehdeh, Marzieh Mojbafan

Henoch-Schönlein purpura (HSP) is a common form of IgA1-mediated blood vessel inflammation affecting mainly children. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms have been shown to be associated with HSP in different populations; in this study, we investigated its potential association and influence on the development of severe complications in Iranian HSP patients. Twenty-three patients diagnosed with IgAV/HSP according to the criteria of the American College of Rheumatology (ACR) with 53 age- and sex-matched control subjects were referred to us. Cases and controls were genotyped using Sanger sequencing. Based on our research data, we found an association between codon 469 K/E of the ICAM1 gene and risk of HSP. Our results revealed that KK genotype and allele K are more common in control than in the HSP group, therefore the subjects with KK genotype are protected against HSP. Our data also suggested that the genotype EE is associated with higher risk of HSP progression compared to KK genotype.

过敏性紫癜(HSP)是一种常见的由 IgA1 介导的血管炎症,主要影响儿童。在不同人群中,细胞间粘附分子-1(ICAM-1)基因多态性已被证明与 HSP 相关;在本研究中,我们调查了其与伊朗 HSP 患者严重并发症发生的潜在关联和影响。根据美国风湿病学会(ACR)的标准,23 名患者被诊断为 IgAV/HSP 患者,53 名年龄和性别匹配的对照受试者被转介给我们。我们使用桑格测序法对病例和对照组进行了基因分型。根据我们的研究数据,我们发现 ICAM1 基因 469 K/E 密码子与 HSP 风险之间存在关联。我们的研究结果显示,KK 基因型和等位基因 K 在对照组中比在 HSP 组中更常见,因此具有 KK 基因型的受试者对 HSP 有保护作用。我们的数据还表明,与 KK 基因型相比,EE 基因型与更高的 HSP 进展风险相关。
{"title":"Association between polymorphism at codon 469 of the ICAM-1 gene and Henoch-Schönlein purpura in an Iranian cohort.","authors":"Shima Salehi, Amir Hozhabrpour, Somayeh Takrim Nojehdeh, Marzieh Mojbafan","doi":"10.1080/15257770.2024.2334360","DOIUrl":"https://doi.org/10.1080/15257770.2024.2334360","url":null,"abstract":"<p><p>Henoch-Schönlein purpura (HSP) is a common form of IgA1-mediated blood vessel inflammation affecting mainly children. Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms have been shown to be associated with HSP in different populations; in this study, we investigated its potential association and influence on the development of severe complications in Iranian HSP patients. Twenty-three patients diagnosed with IgAV/HSP according to the criteria of the American College of Rheumatology (ACR) with 53 age- and sex-matched control subjects were referred to us. Cases and controls were genotyped using Sanger sequencing. Based on our research data, we found an association between codon 469 K/E of the <i>ICAM1</i> gene and risk of HSP. Our results revealed that KK genotype and allele K are more common in control than in the HSP group, therefore the subjects with KK genotype are protected against HSP. Our data also suggested that the genotype EE is associated with higher risk of HSP progression compared to KK genotype.</p>","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel mass spectrometry-based assay for thymidylate synthase activity. 基于质谱的新型胸腺嘧啶酸合成酶活性检测方法。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-25 DOI: 10.1080/15257770.2024.2344187
Krzysztof Urbanowicz, J. Turyn, Ryszard T Smoleński, G. J. Peters
Thymidylate synthase (TS) is an enzyme responsible for the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), with the co-substrate 5,10-methylenetetrahydrofolate (5,10-CH2-THF) as the methyl donor. TS is the only enzyme capable of de novo biosynthesis of dTMP in humans, a nucleotide crucial for DNA synthesis and therefore cell proliferation and survival. As such, TS is a major drug target in chemotherapy by compounds such as 5-fluorouracil. Due to the clinical and physiological importance of TS, the ability to accurately assay its activity is crucial. Several assays have been developed for this purpose, relying on spectrophotometry or radioisotope labeling methods. In this study, we have developed a liquid chromatography - mass spectrometry-based method for assessing TS activity by direct and specific measurement of the reaction product, dTMP. The assay was tested on mouse liver homogenates. We noted that excessive 5,10-CH2-THF concentration (400 µM) led to substrate inhibition and therefore 200 µM was used. The activity assayed at 1 µM dUMP was linear with protein content and time (up to 60 min) and was 0.56 ± 0.12 pmol/mg protein/min, in line with previously reported values. Additionally, by using a high mass resolution Orbitrap instrument side reactions were monitored, revealing major changes in folate pools and nucleotide metabolism. These findings highlight the value of the developed TS assay for routine TS activity monitoring in complex matrixes such as clinical material.
胸苷酸合成酶(TS)是一种负责将单磷酸脱氧尿苷(dUMP)转化为单磷酸脱氧胸苷(dTMP)的酶,辅助底物是作为甲基供体的 5,10-亚甲基四氢叶酸(5,10-CH2-THF)。TS 是人类体内唯一能够从头开始生物合成 dTMP 的酶,而 dTMP 是一种对 DNA 合成至关重要的核苷酸,因此也是细胞增殖和存活的关键。因此,TS 是 5-氟尿嘧啶等化合物化疗的主要药物靶点。由于 TS 在临床和生理上的重要性,准确检测其活性的能力至关重要。为此,已经开发出了几种依赖于分光光度法或放射性同位素标记法的检测方法。在这项研究中,我们开发了一种基于液相色谱-质谱法的方法,通过直接特异性测量反应产物 dTMP 来评估 TS 的活性。该方法在小鼠肝脏匀浆中进行了测试。我们注意到过高的 5,10-CH2-THF 浓度(400 µM)会导致底物抑制,因此使用了 200 µM。在 1 µM dUMP 条件下测定的活性与蛋白质含量和时间(最长 60 分钟)呈线性关系,为 0.56 ± 0.12 pmol/mg 蛋白/分钟,与之前报道的数值一致。此外,通过使用高分辨率 Orbitrap 仪器监测副反应,发现了叶酸池和核苷酸代谢的重大变化。这些发现凸显了所开发的 TS 检测方法在复杂基质(如临床材料)中进行常规 TS 活性监测的价值。
{"title":"Novel mass spectrometry-based assay for thymidylate synthase activity.","authors":"Krzysztof Urbanowicz, J. Turyn, Ryszard T Smoleński, G. J. Peters","doi":"10.1080/15257770.2024.2344187","DOIUrl":"https://doi.org/10.1080/15257770.2024.2344187","url":null,"abstract":"Thymidylate synthase (TS) is an enzyme responsible for the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), with the co-substrate 5,10-methylenetetrahydrofolate (5,10-CH2-THF) as the methyl donor. TS is the only enzyme capable of de novo biosynthesis of dTMP in humans, a nucleotide crucial for DNA synthesis and therefore cell proliferation and survival. As such, TS is a major drug target in chemotherapy by compounds such as 5-fluorouracil. Due to the clinical and physiological importance of TS, the ability to accurately assay its activity is crucial. Several assays have been developed for this purpose, relying on spectrophotometry or radioisotope labeling methods. In this study, we have developed a liquid chromatography - mass spectrometry-based method for assessing TS activity by direct and specific measurement of the reaction product, dTMP. The assay was tested on mouse liver homogenates. We noted that excessive 5,10-CH2-THF concentration (400 µM) led to substrate inhibition and therefore 200 µM was used. The activity assayed at 1 µM dUMP was linear with protein content and time (up to 60 min) and was 0.56 ± 0.12 pmol/mg protein/min, in line with previously reported values. Additionally, by using a high mass resolution Orbitrap instrument side reactions were monitored, revealing major changes in folate pools and nucleotide metabolism. These findings highlight the value of the developed TS assay for routine TS activity monitoring in complex matrixes such as clinical material.","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140653392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality. DPP9 rs2109069 和 IFNAR2 rs2236757 多态性与 COVID-19 死亡率的相关性研究。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-25 DOI: 10.1080/15257770.2024.2344179
Mahnaz Safari, Rezvan Tavakoli, Mohammadreza Aghasadeghi, Akram Sadat Tabatabaee Bafroee, A. Fateh, Pooneh Rahimi
Understanding the complex mechanisms of the immune system in dealing with the COVID-19 infection, which is probably related to the polymorphism in cytokine and chemokine genes, can explain the pro-inflammatory condition of patients. Therefore, in this study, the relationship between the frequency of single nucleotide polymorphisms in the two pro-inflammatory genes dipeptidylpeptidase 9 (DPP9) and interferon alpha and beta receptor subunit 2 (IFNAR2) and the severity of COVID-19 was assessed. This study involved 954 COVID-19 patients, including 528 recovered and 426 deceased patients. To investigate the polymorphisms of IFNAR2 rs2236757 and DPP9 rs2109069, we used the polymerase chain reaction with the restriction fragment length polymorphism assay. The results showed that IFNAR2 rs2236757 A allele is related to the reduced severity of the disease, whereas the incidence of DPP9 rs2109069 A allele was higher among the deceased than recovered individuals. On the other hand, in people carrying the G allele in the DPP9 gene polymorphism and the allele A in the IFNR2 gene polymorphism, the improvement of the disease was significantly higher. In conclusion, the results showed that IFNAR2 rs2236757 A allele is related to the decrease in the severity of the disease, while the frequency of DPP9 rs2109069 A allele was higher in deceased people than in recovered people. This shows the important role of genes related to inflammatory responses as well as the role of genetic variants of these genes in the severity of COVID-19.
了解免疫系统应对 COVID-19 感染的复杂机制(可能与细胞因子和趋化因子基因的多态性有关),可以解释患者的促炎状况。因此,本研究评估了二肽基肽酶 9(DPP9)和干扰素α和β受体亚基 2(IFNAR2)这两种促炎基因的单核苷酸多态性频率与 COVID-19 严重程度之间的关系。这项研究涉及 954 名 COVID-19 患者,包括 528 名康复患者和 426 名死亡患者。为了研究 IFNAR2 rs2236757 和 DPP9 rs2109069 的多态性,我们使用了聚合酶链反应和限制性片段长度多态性检测。结果显示,IFNAR2 rs2236757 A 等位基因与疾病的严重程度降低有关,而 DPP9 rs2109069 A 等位基因在死亡者中的发生率高于康复者。另一方面,在携带 DPP9 基因多态性中的 G 等位基因和 IFNR2 基因多态性中的 A 等位基因的人群中,疾病的好转率明显较高。总之,研究结果表明,IFNAR2 rs2236757 A 等位基因与疾病严重程度的减轻有关,而 DPP9 rs2109069 A 等位基因在死亡者中的频率高于康复者。这表明与炎症反应相关的基因以及这些基因的遗传变异在 COVID-19 的严重程度中发挥着重要作用。
{"title":"Study on the correlation between DPP9 rs2109069 and IFNAR2 rs2236757 polymorphisms with COVID-19 mortality.","authors":"Mahnaz Safari, Rezvan Tavakoli, Mohammadreza Aghasadeghi, Akram Sadat Tabatabaee Bafroee, A. Fateh, Pooneh Rahimi","doi":"10.1080/15257770.2024.2344179","DOIUrl":"https://doi.org/10.1080/15257770.2024.2344179","url":null,"abstract":"Understanding the complex mechanisms of the immune system in dealing with the COVID-19 infection, which is probably related to the polymorphism in cytokine and chemokine genes, can explain the pro-inflammatory condition of patients. Therefore, in this study, the relationship between the frequency of single nucleotide polymorphisms in the two pro-inflammatory genes dipeptidylpeptidase 9 (DPP9) and interferon alpha and beta receptor subunit 2 (IFNAR2) and the severity of COVID-19 was assessed. This study involved 954 COVID-19 patients, including 528 recovered and 426 deceased patients. To investigate the polymorphisms of IFNAR2 rs2236757 and DPP9 rs2109069, we used the polymerase chain reaction with the restriction fragment length polymorphism assay. The results showed that IFNAR2 rs2236757 A allele is related to the reduced severity of the disease, whereas the incidence of DPP9 rs2109069 A allele was higher among the deceased than recovered individuals. On the other hand, in people carrying the G allele in the DPP9 gene polymorphism and the allele A in the IFNR2 gene polymorphism, the improvement of the disease was significantly higher. In conclusion, the results showed that IFNAR2 rs2236757 A allele is related to the decrease in the severity of the disease, while the frequency of DPP9 rs2109069 A allele was higher in deceased people than in recovered people. This shows the important role of genes related to inflammatory responses as well as the role of genetic variants of these genes in the severity of COVID-19.","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An artificial-restriction fragment length polymorphism (A-RFLP) method for genotyping intronic SNP rs7587633 C/T of ATG16L1. 人工限制性片段长度多态性(A-RFLP)方法用于对 ATG16L1 的内含子 SNP rs7587633 C/T 进行基因分型。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-25 DOI: 10.1080/15257770.2024.2344736
Ambika Sharma, Arti Sharma, Jyoti Parkash, H. Changotra
SNPs could either cause a disorder or directly alter the efficacy of a particular treatment and act as biological markers. The SNP rs7587633 C/T present in the intronic region of the ATG16L1 gene has been studied for its role in psoriasis vulgaris and Palmoplantar pustulosis. To genotype rs7587633 C/T using PCR-RFLP no restriction site is present for any of the restriction enzymes at the SNP position. To develop an artificial-RFLP method for genotyping rs7587633 C/T, the forward primer was designed in such a way that it resulted in the creation of an EcoRI restriction site in the amplified product which could further be digested with EcoRI to find the genotype of the individual. The newly developed A-RFLP method was applied to genotype the SNP rs7587633 C/T in DNA samples of 100 healthy control individuals. The allelic and genotypic frequencies of the SNPs were 0.80(C), 0.20(T) and 65%(CC), 31%(CT) and 4%(TT), respectively. In conclusion, we developed an A-RFLP method to genotype the SNP rs7587633 C/T which is not present in any of the natural restriction sites and this method could be applied to genotype this SNP in various populations/diseases to find its role.
SNPs既可能导致疾病,也可能直接改变特定治疗方法的疗效,并可作为生物学标记。研究发现,ATG16L1 基因内含子区的 SNP rs7587633 C/T 在寻常型银屑病和掌跖脓疱病中的作用。使用 PCR-RFLP 对 rs7587633 C/T 进行基因分型时,SNP 位置上不存在任何限制性酶的限制位点。为了开发一种人工 RFLP 方法来对 rs7587633 C/T 进行基因分型,我们设计了一种前向引物,它能在扩增产物中产生一个 EcoRI 限制位点,进一步用 EcoRI 进行消化,从而找到个体的基因型。新开发的 A-RFLP 方法被用于对 100 名健康对照者 DNA 样本中的 SNP rs7587633 C/T 进行基因分型。该 SNP 的等位基因频率和基因型频率分别为 0.80(C)、0.20(T)和 65%(CC)、31%(CT)和 4%(TT)。总之,我们开发了一种 A-RFLP 方法来对不存在于任何天然限制位点的 SNP rs7587633 C/T 进行基因分型,这种方法可用于在不同人群/疾病中对该 SNP 进行基因分型,以发现其作用。
{"title":"An artificial-restriction fragment length polymorphism (A-RFLP) method for genotyping intronic SNP rs7587633 C/T of ATG16L1.","authors":"Ambika Sharma, Arti Sharma, Jyoti Parkash, H. Changotra","doi":"10.1080/15257770.2024.2344736","DOIUrl":"https://doi.org/10.1080/15257770.2024.2344736","url":null,"abstract":"SNPs could either cause a disorder or directly alter the efficacy of a particular treatment and act as biological markers. The SNP rs7587633 C/T present in the intronic region of the ATG16L1 gene has been studied for its role in psoriasis vulgaris and Palmoplantar pustulosis. To genotype rs7587633 C/T using PCR-RFLP no restriction site is present for any of the restriction enzymes at the SNP position. To develop an artificial-RFLP method for genotyping rs7587633 C/T, the forward primer was designed in such a way that it resulted in the creation of an EcoRI restriction site in the amplified product which could further be digested with EcoRI to find the genotype of the individual. The newly developed A-RFLP method was applied to genotype the SNP rs7587633 C/T in DNA samples of 100 healthy control individuals. The allelic and genotypic frequencies of the SNPs were 0.80(C), 0.20(T) and 65%(CC), 31%(CT) and 4%(TT), respectively. In conclusion, we developed an A-RFLP method to genotype the SNP rs7587633 C/T which is not present in any of the natural restriction sites and this method could be applied to genotype this SNP in various populations/diseases to find its role.","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140655548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Angiotensin-converting enzyme I/D gene polymorphism and risk of type 2 diabetes mellitus in Iranian individuals. 伊朗人血管紧张素转换酶 I/D 基因多态性与 2 型糖尿病风险。
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-23 DOI: 10.1080/15257770.2024.2343904
Mohammad Amin Momeni-Moghaddam, Hanieh Chahkandi, Narges Amini Beidokhti, Marziye Rahmani, Davoud Salarbashi, M. Khorasani
This study aimed to examine the relationship between type 2 diabetes mellitus (T2DM) and renin-angiotensin system gene polymorphisms in the Iranian population. Additionally, we performed a straightforward meta-analysis of the present articles to better understand this role. A total of 100 Iranian individuals, 50 patients with T2DM, and 50 age-matched healthy individuals were included in this study. DNA was extracted using the salting-out approach, polymerase chain reaction was used to amplify the angiotensin-converting enzyme (ACE) gene, electrophoresis techniques were used, and genotyping was performed. We also searched PubMed, Web of Science, Scopus, and Google Scholar databases for papers published in 2023. We found a significantly higher frequency of I/D genotype in the patient group than in the control group, and the risk of T2DM was 10 times higher in individuals with the I/D genotype (OR, 10 [95% CI, 3.7 to 27]; p < 0.0001) and also 2.85 time higher in individuals with the D allele OR, 2.85 [95% CI, 1.55 to 5.24]; p < 0.001). The ACE polymorphism alleles D and I/D genotypes may increase the risk of developing T2DM in an Iranian population.
本研究旨在探讨伊朗人群中 2 型糖尿病(T2DM)与肾素-血管紧张素系统基因多态性之间的关系。此外,我们还对目前的文章进行了直接的荟萃分析,以更好地了解这一作用。本研究共纳入 100 名伊朗人,其中包括 50 名 T2DM 患者和 50 名年龄匹配的健康人。采用盐析法提取 DNA,使用聚合酶链反应扩增血管紧张素转换酶(ACE)基因,使用电泳技术并进行基因分型。我们还检索了 PubMed、Web of Science、Scopus 和 Google Scholar 数据库中 2023 年发表的论文。我们发现,患者组中 I/D 基因型的频率明显高于对照组,I/D 基因型患者罹患 T2DM 的风险是对照组的 10 倍(OR,10 [95% CI,3.7 至 27];p < 0.0001),D 等位基因患者罹患 T2DM 的风险是对照组的 2.85 倍(OR,2.85 [95% CI,1.55 至 5.24];p < 0.001)。在伊朗人群中,ACE 多态性等位基因 D 和 I/D 基因型可能会增加患 T2DM 的风险。
{"title":"Angiotensin-converting enzyme I/D gene polymorphism and risk of type 2 diabetes mellitus in Iranian individuals.","authors":"Mohammad Amin Momeni-Moghaddam, Hanieh Chahkandi, Narges Amini Beidokhti, Marziye Rahmani, Davoud Salarbashi, M. Khorasani","doi":"10.1080/15257770.2024.2343904","DOIUrl":"https://doi.org/10.1080/15257770.2024.2343904","url":null,"abstract":"This study aimed to examine the relationship between type 2 diabetes mellitus (T2DM) and renin-angiotensin system gene polymorphisms in the Iranian population. Additionally, we performed a straightforward meta-analysis of the present articles to better understand this role. A total of 100 Iranian individuals, 50 patients with T2DM, and 50 age-matched healthy individuals were included in this study. DNA was extracted using the salting-out approach, polymerase chain reaction was used to amplify the angiotensin-converting enzyme (ACE) gene, electrophoresis techniques were used, and genotyping was performed. We also searched PubMed, Web of Science, Scopus, and Google Scholar databases for papers published in 2023. We found a significantly higher frequency of I/D genotype in the patient group than in the control group, and the risk of T2DM was 10 times higher in individuals with the I/D genotype (OR, 10 [95% CI, 3.7 to 27]; p < 0.0001) and also 2.85 time higher in individuals with the D allele OR, 2.85 [95% CI, 1.55 to 5.24]; p < 0.001). The ACE polymorphism alleles D and I/D genotypes may increase the risk of developing T2DM in an Iranian population.","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140672233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells 核苷类似物、亲脂原药和鞣酸对癌细胞核心信号通路的影响
IF 1.3 4区 生物学 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2024-04-15 DOI: 10.1080/15257770.2024.2339952
Marika A. Frańczak, Claudine van der Sande, Elisa Giovannetti, Godefridus J. Peters
Nucleoside analogs such as gemcitabine (GEM; dFdC) and cytarabine (Ara-C) require nucleoside transporters to enter cells, and deficiency in equilibrative nucleoside transporter 1 (ENT1) can lead to...
核苷类似物(如吉西他滨(GEM;dFdC)和阿糖胞苷(Ara-C))需要核苷转运体才能进入细胞,而平衡核苷转运体1(ENT1)的缺乏可导致核苷代谢紊乱。
{"title":"Effects of nucleoside analogues, lipophilic prodrugs and elaidic acids on core signaling pathways in cancer cells","authors":"Marika A. Frańczak, Claudine van der Sande, Elisa Giovannetti, Godefridus J. Peters","doi":"10.1080/15257770.2024.2339952","DOIUrl":"https://doi.org/10.1080/15257770.2024.2339952","url":null,"abstract":"Nucleoside analogs such as gemcitabine (GEM; dFdC) and cytarabine (Ara-C) require nucleoside transporters to enter cells, and deficiency in equilibrative nucleoside transporter 1 (ENT1) can lead to...","PeriodicalId":19343,"journal":{"name":"Nucleosides, Nucleotides & Nucleic Acids","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140592357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nucleosides, Nucleotides & Nucleic Acids
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1